These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9412253)

  • 21. Fluorodeoxyglucose PET in Neurology and Psychiatry.
    Schöll M; Damián A; Engler H
    PET Clin; 2014 Oct; 9(4):371-90, v. PubMed ID: 26050943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral orbitomedial leucotomy for obsessive-compulsive disorder: a single-case study using positron emission tomography.
    Sachdev P; Trollor J; Walker A; Wen W; Fulham M; Smith JS; Matheson J
    Aust N Z J Psychiatry; 2001 Oct; 35(5):684-90. PubMed ID: 11551286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of positron emission tomography for presurgical localization of eloquent brain areas in children with seizures.
    Duncan JD; Moss SD; Bandy DJ; Manwaring K; Kaplan AM; Reiman EM; Chen K; Lawson MA; Wodrich DL
    Pediatr Neurosurg; 1997 Mar; 26(3):144-56. PubMed ID: 9419031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of cerebral metastases of unknown origin: utility of F-18 FDG positron emission tomography to localize the primary tumor.
    Belhocine T; Bolle S; Alberini JL; Daenen F; Rutten I; Rigo P
    Clin Nucl Med; 2001 Sep; 26(9):793. PubMed ID: 11507305
    [No Abstract]   [Full Text] [Related]  

  • 25. A plea for the elective inclusion of the brain in routine whole-body FDG PET.
    Belhocine T; Weiner SM; Brink I; De Deyn PP; Roland J; Van der Borght T; Flamen P
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):251-6. PubMed ID: 15692807
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder.
    Baxter LR; Schwartz JM; Mazziotta JC; Phelps ME; Pahl JJ; Guze BH; Fairbanks L
    Am J Psychiatry; 1988 Dec; 145(12):1560-3. PubMed ID: 3264118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron emission tomography in the investigation of central nervous system disorders.
    Jamieson D; Alavi A; Jolles P; Chawluk J; Reivich M
    Radiol Clin North Am; 1988 Sep; 26(5):1075-88. PubMed ID: 3047777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inositol phospholipid metabolism in Alzheimer's disease: a positron emission tomographic study.
    Kondo M; Imahori Y; Mori S; Nakajima K
    Ann N Y Acad Sci; 2002 Nov; 977():416-22. PubMed ID: 12480781
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of xanthoma disseminatum: evaluation and monitoring by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Jin S; Chae SY; Chang SE; Suh C; Lee SW; Ryu JS
    Br J Dermatol; 2014 May; 170(5):1177-81. PubMed ID: 24329687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applications of positron emission tomography in psychiatry.
    Parsey RV; Mann JJ
    Semin Nucl Med; 2003 Apr; 33(2):129-35. PubMed ID: 12756645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Functional imaging in brain tumors].
    Borbély K
    Orv Hetil; 2004 Feb; 145(8):411-23. PubMed ID: 15061026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography: human brain function and biochemistry.
    Phelps ME; Mazziotta JC
    Science; 1985 May; 228(4701):799-809. PubMed ID: 2860723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. F-18 FDG brain positron emission tomography and Tl-201 early and delayed SPECT in distinguishing atypical cerebral tumor from cerebral infarction.
    Liu HG; Mountz JM
    Clin Nucl Med; 2003 Mar; 28(3):241-2. PubMed ID: 12592141
    [No Abstract]   [Full Text] [Related]  

  • 34. Positron computed tomography for studies of myocardial and cerebral function.
    Phelps ME; Schelbert HR; Mazziotta JC
    Ann Intern Med; 1983 Mar; 98(3):339-59. PubMed ID: 6219602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain fluorine-18 fluorodeoxyglucose imaging with dual-head coincidence gamma camera: comparison with dedicated ring-detector positron emission tomography.
    Fukuchi K; Hayashida K; Moriwaki H; Fukushima K; Kume N; Katafuchi T; Sago M; Takamiya M; Ishida Y
    AJNR Am J Neuroradiol; 2000 Jan; 21(1):99-104. PubMed ID: 10669232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical positron emission tomography: brain imaging].
    Borbély K
    Orv Hetil; 2002 May; 143(21 Suppl 3):1294-7. PubMed ID: 12077920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping.
    Signorini M; Paulesu E; Friston K; Perani D; Colleluori A; Lucignani G; Grassi F; Bettinardi V; Frackowiak RS; Fazio F
    Neuroimage; 1999 Jan; 9(1):63-80. PubMed ID: 9918728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
    Czech N; Brenner W; Kampen WU; Henze E
    Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
    [No Abstract]   [Full Text] [Related]  

  • 39. Thallium-201 DDC, an alternative radiopharmaceutical for rCBF.
    Van Royen EA
    Nucl Med Commun; 1987 Jul; 8(7):603-10. PubMed ID: 2825091
    [No Abstract]   [Full Text] [Related]  

  • 40. F-18 fluorodeoxyglucose positron emission tomographic imaging in a patient with persistent hiccups.
    Nguyen JD; Dunleavy K; Carrasquillo JA; Chen CC
    Clin Nucl Med; 2004 Jan; 29(1):35-6. PubMed ID: 14688595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.